MX2022009169A - Composiciones y metodos para tratar y prevenir hepatitis b y d. - Google Patents
Composiciones y metodos para tratar y prevenir hepatitis b y d.Info
- Publication number
- MX2022009169A MX2022009169A MX2022009169A MX2022009169A MX2022009169A MX 2022009169 A MX2022009169 A MX 2022009169A MX 2022009169 A MX2022009169 A MX 2022009169A MX 2022009169 A MX2022009169 A MX 2022009169A MX 2022009169 A MX2022009169 A MX 2022009169A
- Authority
- MX
- Mexico
- Prior art keywords
- hepatitis
- compositions
- methods
- treating
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
- C12N2760/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Beans For Foods Or Fodder (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966970P | 2020-01-28 | 2020-01-28 | |
| PCT/US2021/015126 WO2021154752A1 (en) | 2020-01-28 | 2021-01-26 | Compositions and methods for treating and preventing hepatitis b and d |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022009169A true MX2022009169A (es) | 2022-12-08 |
Family
ID=74673345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022009169A MX2022009169A (es) | 2020-01-28 | 2021-01-26 | Composiciones y metodos para tratar y prevenir hepatitis b y d. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230079898A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4096711A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7855515B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220149519A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115335075A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021214939A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3169407A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022009169A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021154752A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564533B (zh) * | 2009-06-12 | 2012-01-04 | 东南大学 | 戊型肝炎蛋白-核酸复合疫苗及其制备方法 |
| CN102895659B (zh) * | 2011-07-29 | 2014-10-29 | 复旦大学 | 一种防治老年痴呆症复合疫苗及其制备方法 |
| US10905760B2 (en) | 2016-01-28 | 2021-02-02 | Svenska Vaccinfabriken Produktion Ab | Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes |
| AU2017332854B2 (en) * | 2016-09-21 | 2024-11-14 | The Governors Of The University Of Alberta | Hepatitis C virus immunogenic compositions and methods of use thereof |
-
2021
- 2021-01-26 CN CN202180022581.7A patent/CN115335075A/zh active Pending
- 2021-01-26 WO PCT/US2021/015126 patent/WO2021154752A1/en not_active Ceased
- 2021-01-26 US US17/794,786 patent/US20230079898A1/en not_active Abandoned
- 2021-01-26 EP EP21707475.6A patent/EP4096711A1/en active Pending
- 2021-01-26 AU AU2021214939A patent/AU2021214939A1/en active Pending
- 2021-01-26 MX MX2022009169A patent/MX2022009169A/es unknown
- 2021-01-26 JP JP2022546448A patent/JP7855515B2/ja active Active
- 2021-01-26 CA CA3169407A patent/CA3169407A1/en active Pending
- 2021-01-26 KR KR1020227029043A patent/KR20220149519A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7855515B2 (ja) | 2026-05-08 |
| AU2021214939A1 (en) | 2022-09-15 |
| KR20220149519A (ko) | 2022-11-08 |
| CN115335075A (zh) | 2022-11-11 |
| JP2023512526A (ja) | 2023-03-27 |
| CA3169407A1 (en) | 2021-08-05 |
| EP4096711A1 (en) | 2022-12-07 |
| US20230079898A1 (en) | 2023-03-16 |
| WO2021154752A1 (en) | 2021-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022009836A (es) | Vacuna para sars-cov-2. | |
| HRP20201873T1 (hr) | Sredstva i postupci za liječenje hbv-a | |
| GB2574561A (en) | Engineering CRISPR CAS9 immune stealth | |
| WO2021222639A3 (en) | Recombinant human metapneumovirus f proteins and their use | |
| EP4599847A3 (en) | Prefusion coronavirus spike proteins and their use | |
| WO2018109220A3 (en) | Novel recombinant prefusion rsv f proteins and uses thereof | |
| JP2016128513A5 (cg-RX-API-DMAC7.html) | ||
| WO2008103380A3 (en) | Hepatitis b virus compositions and methods of use | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| SG156652A1 (en) | Yeast-based therapeutic for chronic hepatitis c infection | |
| EA202090759A3 (ru) | Коровый белок вируса гепатита в и поверхностный антигенный белок и содержащая их вакцина | |
| CL2012000447A1 (es) | Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica. | |
| MX2019000215A (es) | Composiciones inmunogenicas a base de listeria que comprenden antigenos de proteinas del tumor de wilms y metodos para su uso. | |
| WO2020065349A3 (en) | Vaccines and methods | |
| FI3737397T3 (fi) | Prameen kohdistetut syöpärokotteet ja niiden käytöt | |
| RU2018123307A (ru) | Вакцинация с использованием альфа3 домена mica/b для лечения рака | |
| MX2021002147A (es) | Tratamiento de la infección por virus de la hepatitis delta con interferón lambda. | |
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| MX2023012368A (es) | Vacuna de virus. | |
| MX2023000881A (es) | Estructura genomica del virus de la influenza. | |
| MX2025013140A (es) | Composiciones para el uso en el tratamiento del acne | |
| NZ774063A (en) | Injectable composition | |
| PH12020500194A1 (en) | Malaria vaccine | |
| Meseda et al. | Percutaneous vaccination as an effective method of delivery of MVA and MVA-vectored vaccines | |
| ATE435660T1 (de) | Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen |